{
  "version": "1.0",
  "generated": "2026-02-21",
  "description": "Comprehensive BCI industry landscape tracker. Tracks companies, devices, security posture, funding, regulatory milestones, and publication trends. Part of the QIF project's mission to map the BCI security gap.",
  "companies": [
    {
      "name": "Neuralink",
      "type": "invasive",
      "founded": "2016",
      "headquarters": "Fremont, California, USA",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": 680000000,
      "employees_approx": 400,
      "security_posture": "none_published",
      "security_notes": "No public security documentation. Implantable N1 chip with 1024 electrodes and wireless BLE telemetry. FDA IDE approved May 2023. First human implant Jan 2024. ~3 patients enrolled in PRIME study.",
      "tara_attack_surface": ["T0001","T0003","T0005","T0008","T0010","T0015","T0021","T0023","T0025","T0030","T0041","T0043","T0045","T0048","T0061","T0063","T0065","T0081","T0085","T0090","T0095","T0100"],
      "devices": [
        {
          "name": "N1 Chip",
          "type": "invasive",
          "channels": 1024,
          "electrode_type": "penetrating",
          "fda_status": "IDE",
          "units_deployed": "~3 implanted (PRIME study)",
          "first_human": "2024-01",
          "price_usd": null,
          "target_use": "medical",
          "cves_known": []
        },
        {
          "name": "Blindsight",
          "type": "invasive",
          "channels": 1024,
          "electrode_type": "penetrating",
          "fda_status": "breakthrough",
          "units_deployed": "0 (pre-clinical)",
          "first_human": null,
          "price_usd": null,
          "target_use": "medical",
          "cves_known": []
        }
      ]
    },
    {
      "name": "Synchron",
      "type": "semi_invasive",
      "founded": "2016",
      "headquarters": "Brooklyn, New York, USA",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": 145000000,
      "employees_approx": 120,
      "security_posture": "none_published",
      "security_notes": "No public security documentation. Endovascular Stentrode implanted via jugular vein. FDA pivotal trial IDE approved Jul 2023. ~10 patients.",
      "tara_attack_surface": ["T0001","T0005","T0008","T0021","T0023","T0025","T0041","T0043","T0061","T0063","T0081","T0085"],
      "devices": [
        {
          "name": "Stentrode",
          "type": "semi_invasive",
          "channels": 16,
          "electrode_type": "endovascular",
          "fda_status": "IDE",
          "units_deployed": "~10 implanted",
          "first_human": "2022-07",
          "price_usd": null,
          "target_use": "medical",
          "cves_known": []
        }
      ]
    },
    {
      "name": "Blackrock Neurotech",
      "type": "invasive",
      "founded": "2008",
      "headquarters": "Salt Lake City, Utah, USA",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": 10000000,
      "employees_approx": 60,
      "security_posture": "none_published",
      "security_notes": "No public security documentation. Utah Array is the most implanted cortical electrode in history (35+ patients since 2004). Used in BrainGate clinical trials.",
      "tara_attack_surface": ["T0001","T0003","T0005","T0008","T0010","T0021","T0023","T0041","T0043","T0045","T0061","T0063","T0081"],
      "devices": [
        {
          "name": "NeuroPort / Utah Array",
          "type": "invasive",
          "channels": 96,
          "electrode_type": "penetrating",
          "fda_status": "IDE",
          "units_deployed": "35+ implanted since 2004",
          "first_human": "2004-06",
          "price_usd": null,
          "target_use": "research",
          "cves_known": []
        },
        {
          "name": "MoveAgain BCI",
          "type": "invasive",
          "channels": 96,
          "electrode_type": "penetrating",
          "fda_status": "IDE",
          "units_deployed": "<10",
          "first_human": "2023-01",
          "price_usd": null,
          "target_use": "medical",
          "cves_known": []
        }
      ]
    },
    {
      "name": "Precision Neuroscience",
      "type": "invasive",
      "founded": "2021",
      "headquarters": "New York, New York, USA",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": 102000000,
      "employees_approx": 80,
      "security_posture": "none_published",
      "security_notes": "No public security documentation. Layer 7 thin-film electrode array with 1024 channels. Minimally invasive placement (sits on cortical surface).",
      "tara_attack_surface": ["T0001","T0005","T0008","T0021","T0023","T0041","T0043","T0061","T0081"],
      "devices": [
        {
          "name": "Layer 7 Cortical Interface",
          "type": "invasive",
          "channels": 1024,
          "electrode_type": "surface",
          "fda_status": "IDE",
          "units_deployed": "<5 temporary placements",
          "first_human": "2023-01",
          "price_usd": null,
          "target_use": "medical",
          "cves_known": []
        }
      ]
    },
    {
      "name": "Paradromics",
      "type": "invasive",
      "founded": "2015",
      "headquarters": "Austin, Texas, USA",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": 33000000,
      "employees_approx": 40,
      "security_posture": "none_published",
      "security_notes": "No public security documentation. Connexus DDI targets 65,000 electrode channels. Pre-clinical.",
      "tara_attack_surface": ["T0001","T0003","T0005","T0008","T0021","T0023","T0041","T0043","T0061","T0081"],
      "devices": [
        {
          "name": "Connexus Direct Data Interface",
          "type": "invasive",
          "channels": 65000,
          "electrode_type": "penetrating",
          "fda_status": "none",
          "units_deployed": "0 (pre-clinical)",
          "first_human": null,
          "price_usd": null,
          "target_use": "medical",
          "cves_known": []
        }
      ]
    },
    {
      "name": "BrainGate",
      "type": "invasive",
      "founded": "2000",
      "headquarters": "Providence, Rhode Island, USA",
      "status": "research_only",
      "acquired_by": null,
      "funding_total_usd": null,
      "employees_approx": null,
      "security_posture": "none_published",
      "security_notes": "Research consortium (Brown, Stanford, MGH, Case Western). Uses Blackrock Utah Array. Academic research, not commercial. 15+ patients since 2004.",
      "tara_attack_surface": ["T0001","T0005","T0008","T0021","T0023","T0041","T0061","T0081"],
      "devices": [
        {
          "name": "BrainGate System (Utah Array)",
          "type": "invasive",
          "channels": 96,
          "electrode_type": "penetrating",
          "fda_status": "IDE",
          "units_deployed": "15+ research participants",
          "first_human": "2004-06",
          "price_usd": null,
          "target_use": "research",
          "cves_known": []
        }
      ]
    },
    {
      "name": "Emotiv",
      "type": "non_invasive",
      "founded": "2011",
      "headquarters": "San Francisco, California, USA",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": 15000000,
      "employees_approx": 80,
      "security_posture": "basic_encryption",
      "security_notes": "Consumer EEG. Claims AES-128 encryption for data transfer. Cloud platform for data storage. No formal security audit published. Chile Supreme Court ruled against Emotiv in 2023 neurodata privacy case.",
      "tara_attack_surface": ["T0005","T0008","T0010","T0021","T0023","T0025","T0027","T0030","T0041","T0043","T0081","T0085","T0095"],
      "devices": [
        {
          "name": "EPOC X",
          "type": "non_invasive",
          "channels": 14,
          "electrode_type": "wet",
          "fda_status": "exempt",
          "units_deployed": "50,000+ estimated",
          "first_human": "2009-01",
          "price_usd": 849,
          "target_use": "research",
          "cves_known": []
        },
        {
          "name": "Insight",
          "type": "non_invasive",
          "channels": 5,
          "electrode_type": "dry",
          "fda_status": "exempt",
          "units_deployed": "50,000+ estimated",
          "first_human": "2015-01",
          "price_usd": 499,
          "target_use": "consumer",
          "cves_known": []
        },
        {
          "name": "MN8",
          "type": "non_invasive",
          "channels": 2,
          "electrode_type": "dry",
          "fda_status": "exempt",
          "units_deployed": "5,000+ estimated",
          "first_human": "2022-01",
          "price_usd": 299,
          "target_use": "enterprise",
          "cves_known": []
        }
      ]
    },
    {
      "name": "NeuroSky",
      "type": "non_invasive",
      "founded": "2004",
      "headquarters": "San Jose, California, USA",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": 15000000,
      "employees_approx": 30,
      "security_posture": "minimal_claims",
      "security_notes": "Consumer EEG with millions of units sold. MindWave single-channel headset. Minimal security documentation. Bluetooth LE.",
      "tara_attack_surface": ["T0005","T0008","T0021","T0023","T0041","T0081","T0085"],
      "devices": [
        {
          "name": "MindWave Mobile 2",
          "type": "non_invasive",
          "channels": 1,
          "electrode_type": "dry",
          "fda_status": "exempt",
          "units_deployed": "2,000,000+ estimated",
          "first_human": "2011-01",
          "price_usd": 100,
          "target_use": "consumer",
          "cves_known": []
        }
      ]
    },
    {
      "name": "InteraXon (Muse)",
      "type": "non_invasive",
      "founded": "2007",
      "headquarters": "Toronto, Ontario, Canada",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": 60000000,
      "employees_approx": 50,
      "security_posture": "basic_encryption",
      "security_notes": "Consumer meditation/sleep EEG. Claims Bluetooth encryption. Cloud platform with user accounts. No formal security audit published.",
      "tara_attack_surface": ["T0005","T0008","T0021","T0023","T0025","T0041","T0043","T0081","T0085"],
      "devices": [
        {
          "name": "Muse 2",
          "type": "non_invasive",
          "channels": 4,
          "electrode_type": "dry",
          "fda_status": "exempt",
          "units_deployed": "300,000+ estimated",
          "first_human": "2018-01",
          "price_usd": 250,
          "target_use": "consumer",
          "cves_known": []
        },
        {
          "name": "Muse S",
          "type": "non_invasive",
          "channels": 4,
          "electrode_type": "dry",
          "fda_status": "exempt",
          "units_deployed": "200,000+ estimated",
          "first_human": "2020-01",
          "price_usd": 400,
          "target_use": "consumer",
          "cves_known": []
        }
      ]
    },
    {
      "name": "OpenBCI",
      "type": "non_invasive",
      "founded": "2014",
      "headquarters": "Brooklyn, New York, USA",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": 6000000,
      "employees_approx": 20,
      "security_posture": "open_source",
      "security_notes": "Open-source hardware and software. Community-auditable. No formal security certifications. Transparent by design.",
      "tara_attack_surface": ["T0005","T0008","T0021","T0023","T0041","T0043","T0048","T0081","T0085"],
      "devices": [
        {
          "name": "Cyton",
          "type": "non_invasive",
          "channels": 8,
          "electrode_type": "wet",
          "fda_status": "exempt",
          "units_deployed": "15,000+ estimated",
          "first_human": "2015-01",
          "price_usd": 999,
          "target_use": "research",
          "cves_known": []
        },
        {
          "name": "Ganglion",
          "type": "non_invasive",
          "channels": 4,
          "electrode_type": "wet",
          "fda_status": "exempt",
          "units_deployed": "10,000+ estimated",
          "first_human": "2016-01",
          "price_usd": 200,
          "target_use": "research",
          "cves_known": []
        },
        {
          "name": "Galea",
          "type": "non_invasive",
          "channels": 16,
          "electrode_type": "dry",
          "fda_status": "exempt",
          "units_deployed": "<500",
          "first_human": "2023-01",
          "price_usd": 2500,
          "target_use": "research",
          "cves_known": []
        }
      ]
    },
    {
      "name": "NextMind",
      "type": "non_invasive",
      "founded": "2017",
      "headquarters": "Paris, France",
      "status": "acquired",
      "acquired_by": "Snap Inc.",
      "funding_total_usd": 5000000,
      "employees_approx": null,
      "security_posture": "none_published",
      "security_notes": "Visual cortex BCI headband. Acquired by Snap 2022. Product discontinued. No security documentation was ever published.",
      "tara_attack_surface": ["T0005","T0008","T0021","T0023","T0041","T0081"],
      "devices": [
        {
          "name": "NextMind Dev Kit",
          "type": "non_invasive",
          "channels": 8,
          "electrode_type": "dry",
          "fda_status": "not_applicable",
          "units_deployed": "5,000+ dev kits sold",
          "first_human": "2020-01",
          "price_usd": 399,
          "target_use": "consumer",
          "cves_known": []
        }
      ]
    },
    {
      "name": "Kernel",
      "type": "non_invasive",
      "founded": "2016",
      "headquarters": "Culver City, California, USA",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": 53000000,
      "employees_approx": 50,
      "security_posture": "none_published",
      "security_notes": "Research-grade TD-fNIRS helmet. No published security documentation. Bryan Johnson invested $100M+ personally.",
      "tara_attack_surface": ["T0005","T0008","T0021","T0023","T0041","T0043","T0081"],
      "devices": [
        {
          "name": "Flow",
          "type": "non_invasive",
          "channels": 52,
          "electrode_type": "fNIRS",
          "fda_status": "exempt",
          "units_deployed": "<100 (research partnerships)",
          "first_human": "2021-01",
          "price_usd": null,
          "target_use": "research",
          "cves_known": []
        }
      ]
    },
    {
      "name": "CTRL-Labs",
      "type": "non_invasive",
      "founded": "2015",
      "headquarters": "New York, New York, USA",
      "status": "acquired",
      "acquired_by": "Meta Platforms",
      "funding_total_usd": 67000000,
      "employees_approx": null,
      "security_posture": "none_published",
      "security_notes": "EMG wristband reading motor neuron signals. Acquired by Meta 2019 for ~$500M-$1B. Now Meta's neural interface team. No public BCI security docs.",
      "tara_attack_surface": ["T0005","T0008","T0021","T0023","T0041","T0081","T0085"],
      "devices": [
        {
          "name": "EMG Wristband (Meta Neural Interface)",
          "type": "non_invasive",
          "channels": 16,
          "electrode_type": "EMG",
          "fda_status": "not_applicable",
          "units_deployed": "internal prototypes only",
          "first_human": "2018-01",
          "price_usd": null,
          "target_use": "consumer",
          "cves_known": []
        }
      ]
    },
    {
      "name": "Merge Labs",
      "type": "non_invasive",
      "founded": "2023",
      "headquarters": "San Francisco, California, USA",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": null,
      "employees_approx": 10,
      "security_posture": "none_published",
      "security_notes": "Early-stage. BCI headphones concept. No security information available.",
      "tara_attack_surface": ["T0005","T0008","T0021","T0023","T0041","T0081"],
      "devices": [
        {
          "name": "Merge BCI Headphones",
          "type": "non_invasive",
          "channels": null,
          "electrode_type": "dry",
          "fda_status": "none",
          "units_deployed": "0 (concept/prototype)",
          "first_human": null,
          "price_usd": null,
          "target_use": "consumer",
          "cves_known": []
        }
      ]
    },
    {
      "name": "AlterEgo (MIT Media Lab)",
      "type": "non_invasive",
      "founded": "2018",
      "headquarters": "Cambridge, Massachusetts, USA",
      "status": "research_only",
      "acquired_by": null,
      "funding_total_usd": null,
      "employees_approx": null,
      "security_posture": "none_published",
      "security_notes": "Academic research prototype. Subvocalization via jaw/face EMG. 92% word accuracy. No security analysis published.",
      "tara_attack_surface": ["T0005","T0008","T0021","T0023","T0041","T0081","T0085"],
      "devices": [
        {
          "name": "AlterEgo Subvocalization Interface",
          "type": "non_invasive",
          "channels": 7,
          "electrode_type": "EMG",
          "fda_status": "not_applicable",
          "units_deployed": "<10 research prototypes",
          "first_human": "2018-01",
          "price_usd": null,
          "target_use": "research",
          "cves_known": []
        }
      ]
    },
    {
      "name": "Neurosity",
      "type": "non_invasive",
      "founded": "2018",
      "headquarters": "New York, New York, USA",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": 4000000,
      "employees_approx": 15,
      "security_posture": "basic_encryption",
      "security_notes": "Claims on-device processing and encryption. SDK published. BLE communication. No formal security audit.",
      "tara_attack_surface": ["T0005","T0008","T0010","T0021","T0023","T0025","T0041","T0043","T0081","T0085"],
      "devices": [
        {
          "name": "Crown",
          "type": "non_invasive",
          "channels": 8,
          "electrode_type": "dry",
          "fda_status": "exempt",
          "units_deployed": "2,000+ estimated",
          "first_human": "2021-01",
          "price_usd": 999,
          "target_use": "consumer",
          "cves_known": []
        }
      ]
    },
    {
      "name": "BrainCo",
      "type": "non_invasive",
      "founded": "2015",
      "headquarters": "Somerville, Massachusetts, USA",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": 25000000,
      "employees_approx": 100,
      "security_posture": "minimal_claims",
      "security_notes": "Deployed EEG headbands in Chinese classrooms for attention monitoring. Major privacy concerns. Cloud data processing. Minimal security documentation.",
      "tara_attack_surface": ["T0005","T0008","T0010","T0021","T0023","T0025","T0030","T0041","T0043","T0081","T0085","T0095"],
      "devices": [
        {
          "name": "Focus 1",
          "type": "non_invasive",
          "channels": 3,
          "electrode_type": "dry",
          "fda_status": "not_applicable",
          "units_deployed": "10,000+ in Chinese schools",
          "first_human": "2018-01",
          "price_usd": 300,
          "target_use": "enterprise",
          "cves_known": []
        }
      ]
    },
    {
      "name": "Nihon Kohden",
      "type": "non_invasive",
      "founded": "1951",
      "headquarters": "Tokyo, Japan",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": null,
      "employees_approx": 5800,
      "security_posture": "regulatory_compliance",
      "security_notes": "Major medical device manufacturer. Subject to FDA cybersecurity requirements, IEC 62443, HIPAA. Limited public BCI-specific security documentation.",
      "tara_attack_surface": ["T0005","T0008","T0021","T0023","T0025","T0041","T0043","T0045","T0061","T0063","T0081"],
      "devices": [
        {
          "name": "EEG-1200 (Neurofax)",
          "type": "non_invasive",
          "channels": 128,
          "electrode_type": "wet",
          "fda_status": "cleared",
          "units_deployed": "tens of thousands globally",
          "first_human": null,
          "price_usd": 50000,
          "target_use": "medical",
          "cves_known": []
        }
      ]
    },
    {
      "name": "Natus Medical (Integra LifeSciences)",
      "type": "non_invasive",
      "founded": "1989",
      "headquarters": "Middleton, Wisconsin, USA",
      "status": "acquired",
      "acquired_by": "Integra LifeSciences",
      "funding_total_usd": null,
      "employees_approx": null,
      "security_posture": "regulatory_compliance",
      "security_notes": "CRITICAL: Xltek EEG has KNOWN CVEs (CVE-2017-2853, 2867, 2868, 2869). One of the ONLY neurotech companies with publicly disclosed vulnerabilities. ICS-CERT advisories published.",
      "tara_attack_surface": ["T0005","T0008","T0010","T0021","T0023","T0025","T0030","T0041","T0043","T0045","T0061","T0063","T0081","T0085"],
      "devices": [
        {
          "name": "Xltek EEG System",
          "type": "non_invasive",
          "channels": 128,
          "electrode_type": "wet",
          "fda_status": "cleared",
          "units_deployed": "thousands globally (clinical)",
          "first_human": null,
          "price_usd": 60000,
          "target_use": "medical",
          "cves_known": ["CVE-2017-2853","CVE-2017-2867","CVE-2017-2868","CVE-2017-2869"]
        }
      ]
    },
    {
      "name": "g.tec medical engineering",
      "type": "non_invasive",
      "founded": "1999",
      "headquarters": "Schiedlberg, Austria",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": null,
      "employees_approx": 100,
      "security_posture": "none_published",
      "security_notes": "Research-grade EEG/BCI systems used in academic research globally. No published security documentation.",
      "tara_attack_surface": ["T0005","T0008","T0021","T0023","T0025","T0041","T0043","T0045","T0061","T0081"],
      "devices": [
        {
          "name": "g.USBamp",
          "type": "non_invasive",
          "channels": 16,
          "electrode_type": "wet",
          "fda_status": "cleared",
          "units_deployed": "5,000+ (research labs)",
          "first_human": null,
          "price_usd": 15000,
          "target_use": "research",
          "cves_known": []
        },
        {
          "name": "g.Nautilus",
          "type": "non_invasive",
          "channels": 64,
          "electrode_type": "dry",
          "fda_status": "cleared",
          "units_deployed": "2,000+ estimated",
          "first_human": null,
          "price_usd": 25000,
          "target_use": "research",
          "cves_known": []
        }
      ]
    },
    {
      "name": "Apple",
      "type": "non_invasive",
      "founded": "1976",
      "headquarters": "Cupertino, California, USA",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": null,
      "employees_approx": 164000,
      "security_posture": "mature",
      "security_notes": "AirPods Pro are neural-adjacent (NOT direct BCI). FDA-cleared hearing test, health sensors. Industry-leading security (Secure Enclave, E2E encryption). Included for sensor convergence trend. Multiple BCI patents filed.",
      "tara_attack_surface": ["T0021","T0023","T0041","T0081"],
      "devices": [
        {
          "name": "AirPods Pro (2nd gen)",
          "type": "non_invasive",
          "channels": 0,
          "electrode_type": "dry",
          "fda_status": "cleared",
          "units_deployed": "billions (all AirPods models)",
          "first_human": "2022-09",
          "price_usd": 249,
          "target_use": "consumer",
          "cves_known": [],
          "note": "NOT a BCI. Neural-adjacent: hearing test, head tracking, health sensors."
        }
      ]
    },
    {
      "name": "Cognixion",
      "type": "non_invasive",
      "founded": "2017",
      "headquarters": "Santa Barbara, California, USA",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": 12000000,
      "employees_approx": 25,
      "security_posture": "none_published",
      "security_notes": "EEG+AR headset for ALS/cerebral palsy. No public security documentation.",
      "tara_attack_surface": ["T0005","T0008","T0021","T0023","T0041","T0043","T0081"],
      "devices": [
        {
          "name": "ONE Headset",
          "type": "non_invasive",
          "channels": 6,
          "electrode_type": "dry",
          "fda_status": "none",
          "units_deployed": "<100",
          "first_human": "2021-01",
          "price_usd": null,
          "target_use": "medical",
          "cves_known": []
        }
      ]
    },
    {
      "name": "Cortera Neurotechnologies",
      "type": "invasive",
      "founded": "2016",
      "headquarters": "Berkeley, California, USA",
      "status": "active",
      "acquired_by": null,
      "funding_total_usd": null,
      "employees_approx": 15,
      "security_posture": "none_published",
      "security_notes": "Surface cortical electrodes. Pre-clinical. No public security documentation.",
      "tara_attack_surface": ["T0001","T0005","T0008","T0021","T0041","T0061","T0081"],
      "devices": [
        {
          "name": "Cortera Surface Array",
          "type": "invasive",
          "channels": 256,
          "electrode_type": "surface",
          "fda_status": "none",
          "units_deployed": "0 (pre-clinical)",
          "first_human": null,
          "price_usd": null,
          "target_use": "research",
          "cves_known": []
        }
      ]
    }
  ],
  "market_data": {
    "market_size_estimates": [
      {"year": 2024, "value_billion_usd": 2.1, "source": "Grand View Research"},
      {"year": 2030, "value_billion_usd": 6.2, "source": "Grand View Research (projected)", "cagr_percent": 17.1},
      {"year": 2032, "value_billion_usd": 8.4, "source": "Fortune Business Insights (projected)", "cagr_percent": 18.2}
    ],
    "total_funding_tracked_usd": 1800000000,
    "major_funding_rounds": [
      {"company": "Neuralink", "amount_usd": 680000000, "date": "2023-08", "series": "D"},
      {"company": "Synchron", "amount_usd": 145000000, "date": "2024-01", "series": "C"},
      {"company": "Precision Neuroscience", "amount_usd": 102000000, "date": "2024-01", "series": "C"},
      {"company": "CTRL-Labs", "amount_usd": 67000000, "date": "2019-03", "series": "B", "note": "Acquired by Meta for ~$500M-1B"},
      {"company": "Kernel", "amount_usd": 53000000, "date": "2020-06", "series": "C"},
      {"company": "Paradromics", "amount_usd": 33000000, "date": "2023-06", "series": "B"},
      {"company": "InteraXon (Muse)", "amount_usd": 28000000, "date": "2018-01", "series": "B"},
      {"company": "BrainCo", "amount_usd": 25000000, "date": "2018-01", "series": "B"}
    ],
    "government_grants": [
      {"program": "BRAIN Initiative (NIH)", "total_usd": 3000000000, "period": "2014-2025"},
      {"program": "DARPA N3", "total_usd": 104000000, "period": "2018-2022"},
      {"program": "ARPA-H BEACONS", "total_usd": 45000000, "period": "2024-2028"},
      {"program": "EU Human Brain Project", "total_usd": 600000000, "period": "2013-2023"}
    ],
    "acquisition_history": [
      {"target": "CTRL-Labs", "acquirer": "Meta Platforms", "date": "2019-09", "price_usd_estimate": 750000000},
      {"target": "NextMind", "acquirer": "Snap Inc.", "date": "2022-03", "price_usd_estimate": null},
      {"target": "Natus Medical", "acquirer": "Integra LifeSciences", "date": "2023-05", "price_usd_estimate": 3100000000}
    ]
  },
  "policy_timeline": [
    {"date": "2021-10", "event": "Chile constitutional neurorights amendment", "type": "law", "jurisdiction": "Chile"},
    {"date": "2023-03", "event": "FDORA Section 524B: mandatory device cybersecurity", "type": "law", "jurisdiction": "USA (federal)"},
    {"date": "2023-09", "event": "FDA updated premarket cybersecurity guidance", "type": "guidance", "jurisdiction": "USA (federal)"},
    {"date": "2023-11", "event": "OECD neurotechnology recommendation", "type": "standard", "jurisdiction": "International"},
    {"date": "2024-04", "event": "Colorado neural data privacy law", "type": "law", "jurisdiction": "USA (Colorado)"},
    {"date": "2024-09", "event": "California SB 1223 neural data under CCPA", "type": "law", "jurisdiction": "USA (California)"},
    {"date": "2025-02", "event": "EU AI Act prohibited practices take effect", "type": "law", "jurisdiction": "EU"},
    {"date": "2025-05", "event": "Montana neural data privacy law", "type": "law", "jurisdiction": "USA (Montana)"},
    {"date": "2025-06", "event": "Connecticut neural data privacy law", "type": "law", "jurisdiction": "USA (Connecticut)"},
    {"date": "2025-06", "event": "FDA updated postmarket cybersecurity guidance", "type": "guidance", "jurisdiction": "USA (federal)"},
    {"date": "2025-08", "event": "EU AI Act high-risk requirements take effect", "type": "law", "jurisdiction": "EU"},
    {"date": "2025-11", "event": "UNESCO neurotechnology ethics recommendation", "type": "standard", "jurisdiction": "International"},
    {"date": "2026-01", "event": "California SB 1223 neural data protections effective", "type": "law", "jurisdiction": "USA (California)"}
  ],
  "publication_trends": [
    {"year": 2010, "pubmed_bci": 450, "security_bci": 2},
    {"year": 2012, "pubmed_bci": 720, "security_bci": 4},
    {"year": 2015, "pubmed_bci": 1200, "security_bci": 8},
    {"year": 2018, "pubmed_bci": 2100, "security_bci": 15},
    {"year": 2020, "pubmed_bci": 3200, "security_bci": 25},
    {"year": 2022, "pubmed_bci": 4500, "security_bci": 35},
    {"year": 2023, "pubmed_bci": 5800, "security_bci": 45},
    {"year": 2024, "pubmed_bci": 7200, "security_bci": 55},
    {"year": 2025, "pubmed_bci": 8500, "security_bci": 70}
  ],
  "metadata": {
    "data_sources": [
      "Company websites and press releases",
      "SEC filings and Crunchbase",
      "FDA device databases (510(k), PMA, Breakthrough, IDE)",
      "PubMed (approximate BCI search term counts)",
      "NIST NVD for CVE data",
      "ICS-CERT advisories",
      "Grand View Research, Fortune Business Insights",
      "State legislature websites"
    ],
    "limitations": [
      "Funding amounts are approximate. Many companies do not disclose exact figures.",
      "Units deployed are estimates. Most BCI companies do not publish sales data.",
      "PubMed publication counts are approximate order-of-magnitude estimates.",
      "TARA technique IDs mapped by category, not individually validated per company.",
      "Security posture based on public information only. Companies may have unpublished measures.",
      "Market size estimates vary between research firms."
    ],
    "update_frequency": "Quarterly recommended"
  }
}
